HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Levitzki Selected Research

Melanoma (Melanoma, Malignant)

1/2018Impact of the Anticancer Drug NT157 on Tyrosine Kinase Signaling Networks.
7/2013Therapeutic destruction of insulin receptor substrates for cancer treatment.
1/2012Targeting the Immune System to Fight Cancer Using Chemical Receptor Homing Vectors Carrying Polyinosine/Cytosine (PolyIC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexander Levitzki Research Topics

Disease

54Neoplasms (Cancer)
11/2019 - 02/2002
6Breast Neoplasms (Breast Cancer)
01/2016 - 08/2003
4Prostatic Neoplasms (Prostate Cancer)
04/2017 - 04/2007
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2010 - 09/2002
3Melanoma (Melanoma, Malignant)
01/2018 - 01/2012
3Glioblastoma (Glioblastoma Multiforme)
10/2011 - 11/2005
3Inflammation (Inflammations)
06/2005 - 06/2004
2Septic Shock (Toxic Shock Syndrome)
01/2018 - 06/2004
2Multiple Myeloma
02/2014 - 12/2011
2Leukemia
12/2011 - 09/2002
2Carcinoma (Carcinomatosis)
05/2011 - 04/2009
2Glioma (Gliomas)
04/2011 - 09/2002
2Starvation
10/2010 - 07/2007
2Carcinogenesis
06/2010 - 02/2002
2Hematologic Neoplasms (Hematological Malignancy)
05/2007 - 09/2002
2Sarcoma (Soft Tissue Sarcoma)
01/2007 - 01/2004
2Neointima
02/2005 - 10/2004
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2004 - 06/2003
2Lung Neoplasms (Lung Cancer)
08/2003 - 06/2003
1Shock
01/2018
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
12/2017
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2014
1Genomic Instability
08/2013
1Brain Neoplasms (Brain Tumor)
10/2011
1Chromosome Aberrations (Chromosome Abnormalities)
05/2011
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2007
1Papilloma (Papillomatosis)
05/2007
1Colorectal Neoplasms (Colorectal Cancer)
05/2007
1Neoplasm Metastasis (Metastasis)
04/2007

Drug/Important Bio-Agent (IBA)

9Tyrosine Kinase InhibitorsIBA
11/2019 - 09/2002
9TyrphostinsIBA
12/2014 - 09/2002
8ErbB Receptors (EGF Receptor)IBA
04/2014 - 05/2004
7CytokinesIBA
01/2018 - 09/2002
7Phosphotransferases (Kinase)IBA
05/2007 - 02/2002
6Proteins (Proteins, Gene)FDA Link
04/2017 - 05/2005
6Imatinib Mesylate (Gleevec)FDA Link
01/2013 - 09/2002
5RNA (Ribonucleic Acid)IBA
10/2011 - 09/2002
5Double-Stranded RNA (RNA, Double Stranded)IBA
10/2011 - 09/2002
4Tyrosine (L-Tyrosine)FDA Link
11/2019 - 09/2002
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2019 - 09/2002
3Pharmaceutical PreparationsIBA
01/2018 - 10/2002
3AntibodiesIBA
01/2016 - 08/2003
3LigandsIBA
01/2016 - 03/2011
3CytosineIBA
01/2012 - 01/2006
3Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
07/2011 - 08/2002
3Cisplatin (Platino)FDA LinkGeneric
04/2009 - 12/2002
3src-Family KinasesIBA
01/2007 - 02/2003
3Radioisotopes (Radionuclides)IBA
01/2007 - 07/2004
3Antisense RNA (Anti-Sense RNA)IBA
11/2005 - 08/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2005 - 06/2003
3AG 556IBA
06/2005 - 06/2003
2AntigensIBA
12/2017 - 04/2017
2AndrogensIBA
04/2017 - 12/2014
2Poly I-CIBA
04/2017 - 04/2011
2Trastuzumab (Herceptin)FDA Link
01/2016 - 08/2003
2Insulin ReceptorIBA
12/2014 - 07/2013
2Nucleic AcidsIBA
09/2014 - 10/2011
2Epidermal Growth Factor (EGF)IBA
04/2012 - 04/2011
2PolyethyleneimineIBA
04/2012 - 04/2011
2eIF-2 Kinase (eIF 2 Kinase)IBA
01/2012 - 09/2002
2alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
12/2011 - 09/2002
2Benzo(a)pyreneIBA
05/2011 - 06/2010
2Messenger RNA (mRNA)IBA
06/2010 - 08/2004
2Adenosine Triphosphate (ATP)IBA
05/2007 - 01/2006
2AgarIBA
05/2007 - 10/2003
2AG-879IBA
01/2007 - 01/2004
2tyrphostin AGL-2043IBA
02/2005 - 10/2004
2Biomarkers (Surrogate Marker)IBA
05/2004 - 10/2002
2Gefitinib (Iressa)FDA Link
08/2003 - 06/2003
1Bacterial ToxinsIBA
01/2018
1SuperantigensIBA
01/2018
1Tuberculin (PPD)IBA
12/2017
1Recombinant Fusion ProteinsIBA
01/2016
1Docetaxel (Taxotere)FDA Link
12/2014
1Insulin-Like PeptidesIBA
12/2014
1degrasynIBA
02/2014
1Monoclonal AntibodiesIBA
08/2013
1VaccinesIBA
08/2013
1VemurafenibIBA
07/2013
1Toll-Like Receptor 3IBA
01/2012
1Carrier Proteins (Binding Protein)IBA
01/2012
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2012
1UbiquitinIBA
12/2011
1Protein Kinases (Protein Kinase)IBA
04/2011
1AMP-Activated Protein KinasesIBA
04/2011
1Adenosine Monophosphate (AMP)IBA
04/2011
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
04/2011
1ChemokinesIBA
03/2011
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2010
1Amino AcidsFDA Link
10/2010
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
05/2007
1Prostate-Specific Antigen (Semenogelase)IBA
04/2007
1GL-2003IBA
01/2007
1Estrogens (Estrogen)FDA Link
01/2007

Therapy/Procedure

25Therapeutics
11/2019 - 05/2002
3Drug Therapy (Chemotherapy)
04/2009 - 10/2002
2Immunotherapy
11/2019 - 08/2013
2Stents
02/2005 - 10/2004
1Intravenous Administration
04/2011
1Intraperitoneal Injections
03/2011